Compounds > 2,3,4,5-tetrahydroxypentanal

2,3,4,5-tetrahydroxypentanal and n-acetyllactosamine

2,3,4,5-tetrahydroxypentanal has been researched along with n-acetyllactosamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dart, AM; Du, XJ; Gao, XM; Kiriazis, H; McMullen, JR; Nguyen, MN; Su, Y; Yang, Y	1

Other Studies

1 other study(ies) available for 2,3,4,5-tetrahydroxypentanal and n-acetyllactosamine

Article	Year
Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by β American journal of physiology. Heart and circulatory physiology, 2018, 06-01, Volume: 314, Issue:6 Topics: Amino Sugars; Animals; Cardiomyopathies; Disease Models, Animal; Fibrosis; Galectin 3; Genetic Predisposition to Disease; Humans; Male; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Pectins; Phenotype; Receptors, Adrenergic, beta-2; Severity of Illness Index; Up-Regulation; Ventricular Remodeling	2018

Article

Year

Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by β

American journal of physiology. Heart and circulatory physiology, 2018, 06-01, Volume: 314, Issue:6

Topics: Amino Sugars; Animals; Cardiomyopathies; Disease Models, Animal; Fibrosis; Galectin 3; Genetic Predisposition to Disease; Humans; Male; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Pectins; Phenotype; Receptors, Adrenergic, beta-2; Severity of Illness Index; Up-Regulation; Ventricular Remodeling

2018